Butalbital, Acetaminophen And Caffeine Tablet
Product Images NDC 46672-053

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Butalbital, Acetaminophen And Caffeine (NDC 46672-053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mikart, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A110f1bd 2025 4d25 8602 Ac6732c8ea38 01

FDA Label Image

A110f1bd 2025 4d25 8602 Ac6732c8ea38 02

FDA Label Image

A110f1bd 2025 4d25 8602 Ac6732c8ea38 03

FDA Label Image

A110f1bd 2025 4d25 8602 Ac6732c8ea38 04

A110f1bd 2025 4d25 8602 Ac6732c8ea38 04
This is a medication which contains Butalbital, Acetaminophen and Caffeine. It is habit-forming and should be stored in a tight, light-resistant container with a child-resistant closure. The recommended dosage is one or two tablets every four hours with a total daily dose of no more than six tablets. It should be stored at 20-25°C (68-77°F). The package insert should be consulted for full information. The manufacturer is Mikart, LLC located in Atlanta, GA. This medication should be kept out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.